Skip to Content »

Site Map

FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean

The Lancet Oncology


The Lancet Oncology is recognized for providing a global, authoritative, and independent forum for the highest quality clinical oncology research and opinion. With an impact factor of 22.59, the journal ranks fourth out of 194 oncology journals worldwide, is the leading clinical research journal in oncology, and is in the top 0.5% of all scientific journals, of any discipline, globally (2011 Journal Citation Reports®, ©Thomson Reuters 2012).

The Lancet Oncology publishes original research, reviews, personal views, commentaries, and news across the global field of oncology. The journal is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is fast-tracked to publication within 8 weeks of submission and published first online on before the print issue. Articles published in The Lancet Oncology regularly receive coverage in the mainstream print, online, and broadcast media.

Visit to find out more about The Lancet Oncology.

* 2011 Journal Citation Reports, Thomson Reuters© 2012

View all Oncology titles

Editor Information

    D. Collingridge PhD

Impact Factor

* 2011 Journal Citation ReportsĀ®, published by Thomson Reuters

Customer Reviews

The Lancet Oncology
  • Journal
  • Imprint: ELSEVIER
  • ISSN: 14702045
  • 2011 Impact Factor: 22.589*